The analysis of TCGA samples indicates that MAGE-C1 and MAGE-C2 are significantly upregulated in specific cancer types, including skin cutaneous melanoma (SKCM) and lung adenocarcinoma (LUAD). This evidence concerns the gene MAGEC1 and cancer.